Page last updated: 2024-10-24

celecoxib and Radiation Pneumonitis

celecoxib has been researched along with Radiation Pneumonitis in 1 studies

Radiation Pneumonitis: Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.

Research Excerpts

ExcerptRelevanceReference
"Celecoxib was given to mice twice daily for 40 consecutive days starting on the day of local thoracic irradiation (LTI) or 40 or 80 days later."1.39Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib. ( Hunter, NR; Liao, Z; Mason, KA; Milas, L; Thames, HD; Valdecanas, D, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunter, NR1
Valdecanas, D1
Liao, Z1
Milas, L1
Thames, HD1
Mason, KA1

Other Studies

1 other study available for celecoxib and Radiation Pneumonitis

ArticleYear
Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.
    International journal of radiation oncology, biology, physics, 2013, Feb-01, Volume: 85, Issue:2

    Topics: Animals; Celecoxib; Confidence Intervals; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, R

2013